We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

19 hedge funds and large institutions have $5.98M invested in ImmuCell in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital inflows, than outflows

Capital inflows: $494K | Capital outflows: $376K

27% more funds holding

Funds holding: 15 → 19 (+4)

0.77% less ownership

Funds ownership: 13.22% → 12.45% (-0.77%)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
8
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCM
Perritt Capital Management
Illinois
+$168K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$136K
3
RBF Capital
RBF Capital
California
+$107K
4
Essex Investment Management
Essex Investment Management
Massachusetts
+$69.5K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$11.2K

Top Sellers

Rank Fund Capital Flow
1
Heartland Advisors
Heartland Advisors
Wisconsin
-$208K
2
Deutsche Bank
Deutsche Bank
Germany
-$54K
3
Morgan Stanley
Morgan Stanley
New York
-$52.4K
4
Renaissance Technologies
Renaissance Technologies
New York
-$35.2K
5
Wells Fargo
Wells Fargo
California
-$13.9K

ICCC Hedge Fund Activity: Q4 2017 in Review

19 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2017, worth a combined $5.98M — up 38% from $4.34M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ICCC positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 8 trimmed.

The largest buyer was Perritt Capital Management, adding an estimated $168K. The largest seller was Heartland Advisors, cutting an estimated $208K.

  • 19 institutional investors held ImmuCell (ICCC) as of Q4 2017, up from 15 in Q3 2017.
  • Funds reported $5.98M of ImmuCell stock for Q4 2017, up 38% quarter-over-quarter.
  • 4 funds opened new ImmuCell positions in Q4 2017 and 0 closed out, a net change of +4 holders.
  • The largest ImmuCell buyer in Q4 2017 was Perritt Capital Management, an estimated $168K added.
  • The largest ImmuCell seller in Q4 2017 was Heartland Advisors, an estimated $208K sold.

Based on aggregated 13F filings for Q4 2017.